• GS-441524 Prodrug Research Workflows

  2026-08-21

  Build more reliable GS-441524 antiviral and conversion studies by combining controlled solubilization, matrix-specific incubation, and LC–MS/MS measurement. This workflow distinguishes parent-compound exposure from metabolite formation, supporting sharper antiviral screening and pharmacokinetic interpretation.

• AO/PI Double Staining Kit for Organoid Viability

  2026-08-20

  The AO/PI Double Staining Kit converts a rapid fluorescent readout into a practical map of viable, apoptotic, and necrotic cell states. Its single-assay format is especially useful for patient-derived glioma organoids, where drug response can be compared across intact microenvironment-preserving models and dissociated cell suspensions.

• HyperScript First-Strand cDNA Synthesis Kit for qPCR

  2026-08-20

  The HyperScript First-Strand cDNA Synthesis Kit supports RNA template reverse transcription when transcript abundance, length, or secondary structure complicates gene-expression assays. This article translates lessons from a colorectal cancer chemosensitization study into practical decisions for cDNA preparation, qPCR interpretation, and experimental controls.

• I-BET151 (GSK1210151A): Research Guide

  2026-08-19

  I-BET151, also called GSK1210151A, is a selective BET bromodomain inhibitor for mechanistic cancer biology research. It targets BRD2, BRD3, and BRD4, and supports studies of transcriptional regulation, apoptosis, and cell cycle arrest in models including MLL-fusion leukemia.

• AO/PI Double Staining Kit: 5 Lab Scenarios

  2026-08-19

  This scenario-driven guide explains how the AO/PI Double Staining Kit, SKU K2238, can support practical cell viability, apoptosis detection, and necrosis detection workflows. It connects dual-dye interpretation with sample compatibility, handling, quantitative reporting, and evidence-based vendor selection.

• Human iPSC Sensory Neurons Model HSV-1 Latency

  2026-08-18

  Oh et al. establish a scalable human model in which hiPSCs are rapidly differentiated into functional sensory neurons and infected with HSV-1 under latent conditions. The model reproduces multiple hallmarks of neuronal latency, including the absence of infectious virus, reduced lytic transcription, latency-associated transcript expression, viral heterochromatin, and reactivation after forskolin or PI3K inhibition.

• MCC950 sodium: NLRP3 Workflow Guide

  2026-08-18

  MCC950 sodium, also known as CRID3 sodium salt, provides a selective way to test whether NLRP3 drives cytokine release and pyroptosis rather than relying on broad anti-inflammatory effects. This guide translates its use from oxidative-stress endothelial assays to macrophage, PBMC, endotoxemia, and autoimmune disease workflows, with practical controls and troubleshooting.

• GntR Phosphorylation in Streptococcus suis Virulence

  2026-08-17

  The reference study identifies a phosphorylation-dependent switch in which the Streptococcus suis serotype 2 kinase STK modifies the GntR transcription factor at Ser-41, suppressing nox transcription and weakening oxidative-stress resistance. Its integrated genetic, biochemical, transcriptional, redox, and infection models connect a specific phosphorylation event to NADH accumulation and reduced virulence, providing a useful framework for protein phosphorylation signaling research.

• Live-Dead Bacterial Staining Kit: Viability Guide

  2026-08-17

  The Live-Dead Bacterial Staining Kit uses NucGreen dye and EthD-III to distinguish bacteria with intact membranes from bacteria with compromised membranes. This dual-fluorescence bacterial viability assay supports research measurement of bacterial live-dead differentiation, but it does not replace culture, molecular identification, or clinical diagnosis.

• Exosomal Egr2, RNF8/DAPK1, and Ischemic Stroke

  2026-08-16

  The reference study identifies a mechanistic pathway in which Egr2 carried by bone marrow mesenchymal stem cell exosomes protects OGD/R-injured neuronal cells through transcriptional activation of RNF8 and suppression of DAPK1. Its layered use of exosome characterization, promoter assays, rescue experiments, and Co-IP provides a useful framework for evaluating protein and regulatory networks, although validation remains limited to an in vitro neuronal injury model.

• Anti-Diabetic Drugs and Fracture Risk

  2026-08-15

  This systematic review and network meta-analysis integrates randomized evidence to compare fracture outcomes across anti-diabetic drug classes and individual agents in type 2 diabetes. Its main practical contribution is a more comparative safety framework: trelagliptin showed a statistically significant increase in fracture risk, whereas voglibose and albiglutide showed lower risk, while most other agents—including ertugliflozin—did not differ significantly from comparators.

• Ivermectin Workflows for Parasitology Research

  2026-08-14

  Ivermectin is a broad-spectrum anti-parasitic research compound suited to controlled dose-response, motility, viability, and host-cell selectivity workflows. This guide combines practical formulation advice with assay-design lessons from a Gasdermin C study while clearly separating established parasitology applications from exploratory cancer biology.

• Cryo-EM Reveals HCAR3 Agonist Selectivity

  2026-08-14

  Ye et al. used cryo-EM structures and cellular cAMP assays to define how HCAR3 recognizes several agonists and how its binding pocket differs from HCAR2. The study provides a structural framework for interpreting receptor selectivity and guiding lipid metabolism regulation research without relying solely on HCAR2-associated pharmacology.

• HyperScribe T7 High Yield RNA Synthesis Kit Plus

  2026-08-13

  The HyperScribe T7 High Yield RNA Synthesis Kit Plus streamlines high-output RNA production for mRNA rescue, labeled probes, and functional assays. Its scalable reaction format is especially useful for translating the FLCN mRNA rescue findings in Birt-Hogg-Dubé syndrome into reproducible bench workflows.

• ARCA EGFP mRNA (5-moUTP) Workflow Guide

  2026-08-13

  Build a reproducible fluorescence-based transfection control with capped, modified, polyadenylated mRNA rather than relying solely on plasmid DNA or indirect viability readouts. This guide covers cold-chain handling, dose-finding, mammalian-cell delivery, quantitative EGFP analysis, and storage-informed troubleshooting.

16334 records 1/1089 page Next 12345 下5页 Last page